Advanced search
1 file | 661.54 KB

Therapeutic implications of the nuclear factor-kappaB/nuclear receptor cross-talk

Valerie Gossye (UGent) , Guy Haegeman (UGent) and Karolien De Bosscher (UGent)
(2008) FRONTIERS IN BIOSCIENCE. 13. p.4122-4143
Author
Organization

Downloads

  • (...).pdf
    • full text
    • |
    • UGent only
    • |
    • PDF
    • |
    • 661.54 KB

Citation

Please use this url to cite or link to this publication:

Chicago
Gossye, Valerie, Guy Haegeman, and Karolien De Bosscher. 2008. “Therapeutic Implications of the Nuclear factor-kappaB/nuclear Receptor Cross-talk.” Frontiers in Bioscience 13: 4122–4143.
APA
Gossye, V., Haegeman, G., & De Bosscher, K. (2008). Therapeutic implications of the nuclear factor-kappaB/nuclear receptor cross-talk. FRONTIERS IN BIOSCIENCE, 13, 4122–4143.
Vancouver
1.
Gossye V, Haegeman G, De Bosscher K. Therapeutic implications of the nuclear factor-kappaB/nuclear receptor cross-talk. FRONTIERS IN BIOSCIENCE. 2008;13:4122–43.
MLA
Gossye, Valerie, Guy Haegeman, and Karolien De Bosscher. “Therapeutic Implications of the Nuclear factor-kappaB/nuclear Receptor Cross-talk.” FRONTIERS IN BIOSCIENCE 13 (2008): 4122–4143. Print.
@article{429650,
  author       = {Gossye, Valerie and Haegeman, Guy and De Bosscher, Karolien},
  issn         = {1093-9946},
  journal      = {FRONTIERS IN BIOSCIENCE},
  language     = {eng},
  pages        = {4122--4143},
  title        = {Therapeutic implications of the nuclear factor-kappaB/nuclear receptor cross-talk},
  volume       = {13},
  year         = {2008},
}

Web of Science
Times cited: